Farmaka: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Farmaka
Largest movements
- Cash -€69,890
down €69,890 (-18.7%), from €373,576 to €303,686
mainly Net result for the year (-€69,602) and Trade debts (-€288)
- Profit (loss) carried forward -€69,602
down €69,602 (-30.5%), from €228,453 to €158,851
- Gross operating margin -€51,681
down €51,681 (-304%), from -€16,998 to -€68,679
- Financial charges +€860
up €860 (+1,364%), from €63 to €923
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €373,576 | €303,686 | -€69,890 | -18.7% |
| Current assets | 29/58 | €373,576 | €303,686 | -€69,890 | -18.7% |
| Cash at bank and in hand | 54/58 | €373,576 | €303,686 | -€69,890 | -18.7% |
| Total equity and liabilities | 10/49 | €373,576 | €303,686 | -€69,890 | -18.7% |
| Equity | 10/15 | €373,289 | €303,686 | -€69,602 | -18.6% |
| Contributions | 10/11 | €111,125 | €111,125 | = | 0.0% |
| Capital | 10 | €111,125 | €111,125 | = | 0.0% |
| Reserves | 13 | €33,711 | €33,711 | = | 0.0% |
| Profit (loss) carried forward | 14 | €228,453 | €158,851 | -€69,602 | -30.5% |
| Amounts payable | 17/49 | €288 | €0 | -€288 | -100% |
| Amounts payable within one year | 42/48 | €288 | €0 | -€288 | -100% |
| Trade debts | 44 | €288 | €0 | -€288 | -100% |
| Suppliers | 440/4 | €288 | €0 | -€288 | -100% |
| Gross operating margin | 9900 | -€16,998 | -€68,679 | -€51,681 | -304% |
| Operating profit (loss) | 9901 | -€16,998 | -€68,679 | -€51,681 | -304% |
| Financial income | 75/76B | €0 | €0 | -€0 | -100% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100% |
| Financial charges | 65/66B | €63 | €923 | +€860 | +1,364% |
| Recurring financial charges | 65 | €63 | €923 | +€860 | +1,364% |
| Profit (loss) for the period before taxes | 9903 | -€17,061 | -€69,602 | -€52,541 | -308% |
| Profit (loss) for the period | 9904 | -€17,061 | -€69,602 | -€52,541 | -308% |
| Profit (loss) for the period to be appropriated | 9905 | -€17,061 | -€69,602 | -€52,541 | -308% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.